Matt Biegler

Stock Analyst at Oppenheimer

(n/a)

# 5,049

Out of 5,126 analysts

3

Total ratings

n/a

Success rate

-66.06%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matt Biegler

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	OKUR OnKure Therapeutics	Maintains: Outperform	$35 → $30	$2.50	+1,100.00%	2	Mar 11, 2025
	ALLO Allogene Therapeutics	Maintains: Outperform	$11 → $10	$1.69	+491.72%	1	Nov 8, 2024

OnKure Therapeutics

Mar 11, 2025

Maintains: Outperform

Price Target: $35 → $30

Current: $2.50

Upside: +1,100.00%

Allogene Therapeutics

Nov 8, 2024

Maintains: Outperform

Price Target: $11 → $10

Current: $1.69

Upside: +491.72%